Skip to main content
OpenTrials

Clinical trial condition

FGFR3 Gene Fusions

Explore clinical trials studying FGFR3 Gene Fusions. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

FGFR3 Gene Fusions trial results

Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

NCT06995677

Conditions
Carcinoma, FGFR Gene Alterations, FGFR Gene Amplification, +18 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • Tri Valley Urology - Murrieta Murrieta, California, United States
  • Eisenhower Medical Associates Rancho Mirage, California, United States
View all 46 locations
View Trial Details
Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

NCT06915753

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +26 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF Medical Center at Mount Zion San Francisco, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • The University of Kansas Medical Center Westwood, Kansas, United States
View all 16 locations
View Trial Details

Related conditions